CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $132,000 | -2.2% | 7,161 | -2.8% | 0.00% | -100.0% |
| Q3 2020 | $135,000 | +19.5% | 7,368 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $113,000 | 0.0% | 7,535 | +5.2% | 0.00% | 0.0% |
| Q1 2020 | $113,000 | -8.1% | 7,163 | -5.5% | 0.00% | – |
| Q4 2019 | $123,000 | +7.9% | 7,577 | -0.8% | 0.00% | – |
| Q3 2019 | $114,000 | -10.2% | 7,640 | -0.7% | 0.00% | – |
| Q2 2019 | $127,000 | -0.8% | 7,694 | +4.0% | 0.00% | – |
| Q1 2019 | $128,000 | -5.2% | 7,400 | -3.1% | 0.00% | -100.0% |
| Q4 2018 | $135,000 | -3.6% | 7,639 | -0.8% | 0.00% | – |
| Q3 2018 | $140,000 | -5.4% | 7,697 | +1.8% | 0.00% | -100.0% |
| Q2 2018 | $148,000 | +68.2% | 7,559 | +1.0% | 0.00% | – |
| Q1 2017 | $88,000 | -4.3% | 7,487 | +7.1% | 0.00% | – |
| Q4 2016 | $92,000 | -99.9% | 6,991 | -0.3% | 0.00% | – |
| Q3 2016 | $101,645,000 | +21.1% | 7,010 | +0.1% | 0.00% | – |
| Q2 2016 | $83,930,000 | -21.6% | 7,000 | +21.5% | 0.00% | – |
| Q1 2016 | $107,000,000 | -13.7% | 5,762 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $124,000,000 | +126430.6% | 5,762 | -0.2% | 0.00% | – |
| Q3 2015 | $98,000 | -100.0% | 5,772 | +0.1% | 0.00% | -100.0% |
| Q2 2015 | $216,283,000 | – | 5,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|